Neuronox uses the same botulinum toxin strain as Botox (Clostridium botulinum type A) but with an optimized Korean purification process. The difference lies in advanced lyophilization technology that better preserves molecular activity, resulting in greater purity, superior stability, and more predictable effects. It is the Asian technological evolution applied to botulinum toxin.
Neuronox meets the same international standards as Botox. It is approved in more than 60 countries including Europe and Asia. The advantage is that it uses cutting-edge Korean technology in molecular purification, resulting in a product with fewer impurities and greater consistency. Clinical studies show a safety profile equivalent to or superior to Botox.
Neuronox offers better cost-benefit ratio due to economies of scale in the Korean industry and lower marketing costs vs Western brands. This allows offering cutting-edge technology at a more accessible price without compromising quality. It is the Asian philosophy: maximum efficiency, fair price, superior quality.
Neuronox has similar or slightly longer duration than Botox (3-6 months) due to its greater molecular purity. Patients report high satisfaction with the naturalness of the result and the gradual effect. The advantage lies in consistency: more predictable results session after session due to the product's superior stability.
